Evaluation of Progesterone Agent Utilization and Birth Outcomes in a State Medicaid Plan

February 24, 2017
Image of poster
Tasmina Hydery, PharmD, MBA, CGP
Commonwealth Medicine
Mylissa Price, MPH, BS, RPh
Commonwealth Medicine
Bonnie C. Greenwood, PharmD, BCPS
Commonwealth Medicine
Mito Takeshita, PharmD
University of Massachusetts Medical School
Rose Mauro, MPH, CPh
University of Massachusetts Medical School
Parag Kunte, MPH
University of Massachusetts Medical School
Kimberly Lenz, PharmD, MBA, FAMCP
Commonwealth Medicine

An analysis of medication adherence and birth outcomes among members receiving progesterone for the prevention of preterm birth in a state Medicaid program. Data is also used to evaluate the association between member characteristics and medication adherence and birth outcomes as well as whether there was a change in the cost of care.

Evaluation of Progesterone Agent Utilization and Birth Outcomes in a State Medicaid Plan

Conference 
American Drug Utilization Review Society 2017